BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22250781)

  • 1. Identification of novel adenosine A(2A) receptor antagonists by virtual screening.
    Langmead CJ; Andrews SP; Congreve M; Errey JC; Hurrell E; Marshall FH; Mason JS; Richardson CM; Robertson N; Zhukov A; Weir M
    J Med Chem; 2012 Mar; 55(5):1904-9. PubMed ID: 22250781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility.
    Federico S; Paoletta S; Cheong SL; Pastorin G; Cacciari B; Stragliotto S; Klotz KN; Siegel J; Gao ZG; Jacobson KA; Moro S; Spalluto G
    J Med Chem; 2011 Feb; 54(3):877-89. PubMed ID: 21214204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.
    Congreve M; Andrews SP; Doré AS; Hollenstein K; Hurrell E; Langmead CJ; Mason JS; Ng IW; Tehan B; Zhukov A; Weir M; Marshall FH
    J Med Chem; 2012 Mar; 55(5):1898-903. PubMed ID: 22220592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel 1,3,5-triazine as adenosine A
    Masih A; Agnihotri AK; Srivastava JK; Pandey N; Bhat HR; Singh UP
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22659. PubMed ID: 33156955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists.
    Taliani S; Pugliesi I; Barresi E; Simorini F; Salerno S; La Motta C; Marini AM; Cosimelli B; Cosconati S; Di Maro S; Marinelli L; Daniele S; Trincavelli ML; Greco G; Novellino E; Martini C; Da Settimo F
    J Med Chem; 2012 Feb; 55(4):1490-9. PubMed ID: 22257095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
    Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.
    Zhou G; Aslanian R; Gallo G; Khan T; Kuang R; Purakkattle B; De Ruiz M; Stamford A; Ting P; Wu H; Wang H; Xiao D; Yu T; Zhang Y; Mullins D; Hodgson R
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1348-54. PubMed ID: 26781932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides.
    Inamdar GS; Pandya AN; Thakar HM; Sudarsanam V; Kachler S; Sabbadin D; Moro S; Klotz KN; Vasu KK
    Eur J Med Chem; 2013 May; 63():924-34. PubMed ID: 23685887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substructure-based virtual screening for adenosine A2A receptor ligands.
    van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
    ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
    Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
    J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In search of novel ligands using a structure-based approach: a case study on the adenosine A
    Lenselink EB; Beuming T; van Veen C; Massink A; Sherman W; van Vlijmen HW; IJzerman AP
    J Comput Aided Mol Des; 2016 Oct; 30(10):863-874. PubMed ID: 27629350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
    Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
    Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor.
    Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH
    ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.
    Katritch V; Jaakola VP; Lane JR; Lin J; Ijzerman AP; Yeager M; Kufareva I; Stevens RC; Abagyan R
    J Med Chem; 2010 Feb; 53(4):1799-809. PubMed ID: 20095623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones.
    Harris JM; Neustadt BR; Zhang H; Lachowicz J; Cohen-Williams M; Varty G; Hao J; Stamford AW
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2497-501. PubMed ID: 21398125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Fc-Small Molecule Conjugate for Targeted Inhibition of the Adenosine 2A Receptor.
    Hsiao PY; Kalin JH; Sun IH; Amin MN; Lo YC; Chiang MJ; Giddens J; Sysa-Shah P; Gabrielson K; Wang LX; Powell JD; Cole PA
    Chembiochem; 2016 Oct; 17(20):1951-1960. PubMed ID: 27432157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
    Sanders MP; Roumen L; van der Horst E; Lane JR; Vischer HF; van Offenbeek J; de Vries H; Verhoeven S; Chow KY; Verkaar F; Beukers MW; McGuire R; Leurs R; Ijzerman AP; de Vlieg J; de Esch IJ; Zaman GJ; Klomp JP; Bender A; de Graaf C
    J Med Chem; 2012 Jun; 55(11):5311-25. PubMed ID: 22563707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.
    Scatena A; Fornai F; Trincavelli ML; Taliani S; Daniele S; Pugliesi I; Cosconati S; Martini C; Da Settimo F
    ACS Chem Neurosci; 2011 Sep; 2(9):526-35. PubMed ID: 22860174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.
    Stössel A; Schlenk M; Hinz S; Küppers P; Heer J; Gütschow M; Müller CE
    J Med Chem; 2013 Jun; 56(11):4580-96. PubMed ID: 23631427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.